ELEVEN BIOTHERAPEUTICS INC - COM (EBIO)

CUSIP: 286221106

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class
Equity / COM
Total 13F shares
11,695,222
Share change
-1,828
Total reported value
$130,326,363
Price per share
$11.14
Number of holders
41
Value change
-$38,170
Number of buys
18
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 286221106?
CUSIP 286221106 identifies EBIO - ELEVEN BIOTHERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ELEVEN BIOTHERAPEUTICS INC - COM (EBIO) as of Q3 2014

As of 30 Sep 2014, ELEVEN BIOTHERAPEUTICS INC - COM (EBIO) was held by 41 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,695,222 shares. The largest 10 holders included Third Rock Ventures, LLC, Flagship Ventures 2007 General Partner LLC, FMR LLC, Broadfin Capital, LLC, FRANKLIN RESOURCES INC, JPMORGAN CHASE & CO, Sectoral Asset Management Inc, CAM Group Holding A/S, BlackRock Fund Advisors, and PRINCIPAL FINANCIAL GROUP INC. This page lists 41 institutional shareholders reporting positions in this security for the Q3 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.